Biotest Aktiengesellschaft (BIO) Stock Chart & Stock Price History €40.20 0.00 (0.00%) As of 06/10/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesBuy This Stock Biotest Aktiengesellschaft Stock Price Performance The Biotest Aktiengesellschaft (BIO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 3.83%, with a year-to-date return of -2.43%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Biotest Aktiengesellschaft traded at €40.20 with a market cap of €795.56 million and volume of 19 shares. Five years ago, the stock traded at €23.00, representing a 74.78% increase over that period. At the time, it had a market cap of €455.07 million and a volume of 675 shares. Receive BIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biotest Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance0.00%3 Month Performance-4.74%Year-To-Date Performance-2.43%1 Year PerformanceN/A5 Year Performance+74.78% BIO Stock Chart for Friday, August, 8, 2025 BIO Chart by TradingView Biotest Aktiengesellschaft Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025€40.20€40.20€40.20€40.2019 shs$795.56 million08/06/2025€40.20€40.20€40.20€40.2019 shs$795.56 million08/05/2025€40.20€40.20€40.20€40.2019 shs$795.56 million08/04/2025€40.20€40.20€40.20€40.2019 shs$795.56 million08/01/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/31/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/30/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/29/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/28/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/25/2025€40.20€40.20€40.20€40.2019 shs$795.56 million Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biotest Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/23/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/22/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/21/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/18/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/17/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/16/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/15/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/14/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/11/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/10/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/09/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/08/2025€40.20€40.20€40.20€40.2019 shs$795.56 million07/07/2025€40.20€40.20€40.20€40.2019 shs$795.56 million Related Companies MDG1 Stock Price Chart GNFT Stock Price Chart GXI Stock Price Chart EVT Stock Price Chart DRW3 Stock Price Chart COP Stock Price Chart RHK Stock Price Chart SBS Stock Price Chart FIE Stock Price Chart FRE Stock Price Chart Receive BIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biotest Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. This page (ETR:BIO) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotest Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotest Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts